U.S. House committee launches probe of Trump WHO aid cutoff

Published 04/27/2020, 02:10 PM
Updated 04/27/2020, 02:15 PM
© Reuters. FILE PHOTO: U.S. President Trump leads the daily coronavirus disease (COVID-19) outbreak task force briefing at the White House in Washington

WASHINGTON (Reuters) - The U.S. House of Representatives Foreign Affairs Committee launched an investigation on Monday of President Donald Trump's blocking of funds for the World Health Organization, giving the State Department a week to provide information about the decision as the world faces the coronavirus pandemic.

Democratic Representative Eliot Engel, the committee's chairman, said the U.N. health agency is "imperfect" and that he would support reforms. "But, certainly, cutting the WHO’s funding while the world confronts the COVID-19 tragedy is not the answer," he said in a letter to Secretary of State Mike Pompeo.

COVID-19 is the illness caused by the coronavirus.

In the letter, Engel asked the State Department to provide 11 sets of documents or other information related to the decision to withhold funding no later than 5 p.m. on May 4.

If it does not do so, Engel said the committee would consider all measures at its disposal. A spokesman declined to provide specifics. Engel has the authority as a committee chairman to issue subpoenas to federal agencies.

The requested materials included a list of interagency meetings between Dec. 1 and April 14 at which funding for the WHO was discussed, a list of legal authorities under which the administration will execute the suspension of funds and documents related to the administration's investigation of the WHO.

The State Department did not immediately respond to a request for comment.

Trump suspended U.S. contributions to the WHO on April 14, accusing it of being "China-centric and promoting China's "disinformation" about the coronavirus outbreak and saying his administration would launch a review of the organization.

WHO officials have denied the claims and China insists it has been transparent and open. The United States is the WHO's biggest donor.

Trump's decision prompted immediate criticism from U.S. allies abroad, and within the United States, from health experts and Democrats.

Some Democrats accused the Republican president of using the WHO and China as scapegoats to distract from what they view as Trump's mishandling of a pandemic that has killed nearly 55,000 Americans and cratered the U.S. economy.

But Trump's fellow Republicans have largely backed the president, praising his handling of the health crisis and calling on WHO Director General Tedros Adhanom Ghebreyesus to resign.

© Reuters. FILE PHOTO: U.S. President Trump leads the daily coronavirus disease (COVID-19) outbreak task force briefing at the White House in Washington

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.